FDA Drug recall D-0660-2022
Trimix (Alprostadil/Papaverine/Phentolamine) 20 mcg/30 mg/0.5 mg Injectable 5 mL vials, Rx only, Family Pharmacy of Statesville, Inc
- FDA Drug
- Class II
- terminated
- Published 2022-03-23
On 2022-03-23 the FDA classified a Class II recall of Trimix (Alprostadil/Papaverine/Phentolamine) 20 mcg/30 mg/0.5 mg Injectable 5 mL vials, Rx only, Family Pharmacy of Statesville, Inc by Family Pharmacy, citing lack of Assurance of Sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0660-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-08-06 |
| Published | 2022-03-23 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Family Pharmacy |
| Distribution | NC |
Product
Trimix (Alprostadil/Papaverine/Phentolamine) 20 mcg/30 mg/0.5 mg Injectable 5 mL vials, Rx only, Family Pharmacy of Statesville, Inc.
Reason
Lack of Assurance of Sterility
Identifiers
| code_info | Lot #: 07212020@ BUD: 9/4/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0660-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.